Myelin basic protein — Drug Target

All drugs that target Myelin basic protein — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Immunomodulator

Phase 3 pipeline (1)

• copolymer 1 · National Center for Research Resources (NCRR) · Immunomodulator · Neurology
  Copolymer 1 is a synthetic polymer that works by inducing an immune response against the myelin basic protein, thereby reducing inflammation in the central nervous system.